Advocacy & Practice Updates — Advocacy & Practice
ASRS, Ophthalmic Groups Urge CMS to Consider Relief From Diabetes Cost Measure for 2022 MIPS
This week, ASRS, along with AAO and ASCRS, met with CMS to reiterate our recommendation that retina specialists and other ophthalmologists be exempted from scoring on the MIPS diabetes episode-based cost measure for the 2022 performance year/2024 payment year. We noted that CMS implemented methodology that inappropriately attributed this measure to retina specialists, who do not treat the underlying diabetic disease the measure is targeting and have no way of influencing their performance on it. CMS has already agreed to make the change for 2023 performance and noted on the call they would look into options to make the change for 2022 as well.
ASRS members helped make a difference for 2023 performance, and there’s still time to help with 2022. If your practice was scored on the measure for 2022 and have not yet submitted a targeted review, you have until Monday, October 9 to do so. Log-in to your CMS QPP portal to initiate the review.
Contact Allison Madson, ASRS vice president of health policy, at allison.madson@asrs.org if you need additional assistance.
Posted October 5, 2023